Evotec SE (EVO) Retained Earnings (2009 - 2026)
Evotec SE (EVO) posted Retained Earnings of $1.7 million for Q1 2026, up 0.61% sequentially from $1.7 million in Q4 2025, and up 11.46% YoY from $1.5 million in Q1 2025.
Evotec SE (EVO) Retained Earnings (2009 - 2026) Analysis & Trends
Evotec SE has reported Retained Earnings for 9 years, with the latest figure at $1.7 million in Q1 2026.
- Quarterly Retained Earnings rose 11.46% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (up 11.46% YoY) and the FY2025 annual result came in at $1.7 million, down 99.89% from the prior year.
- Retained Earnings improved to $1.7 million in Q1 2026 per EVO's latest filing, from $1.7 million in the prior quarter.
- Over five years, Retained Earnings peaked at $1.6 billion in Q4 2023 and troughed at $1.4 million in Q3 2022.
- A 5-year average of $417.8 million and a median of $1.7 million in 2025 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings surged 693.41% in 2022, then tumbled 99.89% in 2025.
- Over 5 years, Retained Earnings stood at $1.5 billion in 2022, then increased by 6.17% to $1.6 billion in 2023, then decreased by 0.34% to $1.6 billion in 2024, then sank by 99.89% to $1.7 million in 2025, then gained by 0.61% to $1.7 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered $1.7 million, $1.7 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 3.75 Bn |
| 10 | Evotec SE | 687.23 Mn | 686.75 Mn | - | 1.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.71 Mn |
| Dec 31, 2025 | 1.70 Mn |
| Sep 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | 1.65 Mn |
| Mar 31, 2025 | 1.53 Mn |
| Dec 31, 2024 | 1.55 Bn |
| Sep 30, 2024 | 1.59 Mn |
| Dec 31, 2023 | 1.56 Bn |
| Dec 31, 2022 | 1.47 Bn |
| Sep 30, 2022 | 1.45 Mn |
| Mar 31, 2022 | 1.61 Mn |
| Dec 31, 2021 | -247.58 Mn |
| Sep 30, 2021 | 1.22 Mn |
| Dec 31, 2020 | -515.83 Mn |
| Sep 30, 2010 | -797,917.39 |
| Jun 30, 2010 | -789,128.24 |
| Mar 31, 2010 | -858.78 |
| Dec 31, 2009 | -913,956.72 |